Ellagic acid induces novel and atypical PKC isoforms and promotes caspase-3 dependent apoptosis by blocking energy metabolism

Nutrition and Cancer

Volumn 66, Issue 4, 2014, Pages 675-681

  Mishra, Sudha ^a   Vinayak, Manjula ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CASPASE 3; ELLAGIC ACID; ISOENZYME; LACTATE DEHYDROGENASE; PROTEIN KINASE C; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C ETA; PROTEIN KINASE C THETA; PROTEIN KINASE C ZETA; RNA 18S; RNA 28S; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CASP3 PROTEIN, MOUSE; PKC-3 PROTEIN; PLANT MEDICINAL PRODUCT;

ANAEROBIC METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME REGULATION; LYMPHOMA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; AKR MOUSE; ANIMAL; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG EFFECTS; GENETICS; METABOLISM; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

MUS;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; CASPASE 3; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; ELLAGIC ACID; ENERGY METABOLISM; ISOENZYMES; L-LACTATE DEHYDROGENASE; MICE; MICE, INBRED AKR; PHYTOCHEMICALS; PROTEIN KINASE C; SIGNAL TRANSDUCTION;

EID: 84899902674     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2013.878735     Document Type: Article

References (30)

1. Birt DB, Hendrich S, and Wang W: Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Therap 90, 157-177, 2001.
2. Mullick T and Gasser E: Nutrition in the chemoprevention of gastrointestinal cancer: where are we in the new millennium. Nutrition issues in the gastroenterology. Pract Gastroenterol 16, 52-64, 2004.
3. Fjaeraa C and Nanberg E: Effect of ellagic acid on proliferation, cell adhesion and apoptosis in SH-SY5Y human neuroblastoma cells. Biomedicine & Pharmacotherapy 63, 254-261, 2009.
4. Losso JN, Bansode RR, Trappey A, Bawadi HA, and Truax R: In vitro anti-proliferative activities of ellagic acid. J Nutr Biochem 15, 672-678, 2004.
5. Singh K, Khanna AK, and Chander R: Hepatoprotective effect of ellagic acid against carbon tetrachloride induced hepatotoxicity in rats. Indian J Exp Biol 37, 1025-1026, 1999.
6. Singh MP, Singh G, and Singh SM: Role of host's antitumor immunity in exercise dependent regression of murine T-cell lymphoma. Comp. Immunl Microbiol Infect Disease 28, 231-248, 2005.
7. Haughian JM, Jackson TA, Koterwas DM, and Bradford AP: Endometrial cancer cell survival and apoptosis is regulated by protein kinase C alpha and delta. Endocr Relat Cancer 13, 1251-1267, 2006.
8. Ruvolo VR, Karanjeet KB, Schuster TF, Brown R, Deng Y, et al.: Role for PKC θ in fenretinide-mediated apoptosis in lymphoid leukemia cells. Journal of Signal Transduction 15, 2010.
9. Humphries MJ, Limesand KH, Schneider JC, Nakayama KI, Anderson SM, et al.: Suppression of apoptosis in the protein kinase Cθ null mouse in vivo. Journal of Biol Chem 281, 9728-9737, 2006.
10. Mishra S and Vinayak M: Ellagic acid checks lymphoma promotion via regulation of PKC signaling pathway.Mol Biol Rep 40, 1417-1428, 2013.
11. Mishra S and VinayakM: Anti-carcinogenic action of ellagic acid mediated via modulation of oxidative stress regulated genes in Dalton lymphoma bearing mice. Leuk Lymphoma 52, 2155-2216, 2011.
12. Jackson DN and Foster DA: The enigmatic protein kinase c delta: complex roles in cell proliferation and survival. FASEB J 18, 627-636, 2004.
13. Ohba M, Ishino K, KashiwagiM, Kashiwagi M, Kawabe S, et al.: Induction of differentiation in normal human keratinocytes by adeno virus mediated introduction of the eta and delta isoforms of protein kinase C. Mol Cell Biol 18, 5199-5207, 1998.
14. Emoto Y, Manome Y, Meinhardt G, and Kisaki H: Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells. EMBO J 14, 6148-6156, 1995.
15. Kim JH, Kim JH, Ohba M, Suh PG, Ryn SH, et al.: Novel functions of the phospholipase D2-Phox homology domain in protein kinase C zeta activation. Mol Cell Biol 25, 3194-3208, 2005.
16. Sanz-Navares E, Fernandez N, Kazanietz MG, and Rotenberg SA: Atypical protein kinase C zeta suppresses migration of mouse melanoma cells. Cell Growth Differ 12, 517-524, 2001.
17. Zhang L, Huang J, Yang N, Yang N, Liang S, et al.: Integrative genomic analysis of protein kinaseC(PKC) family identifiesPKCiota as a biomarker and potential oncogene in ovarian carcinoma. Cancer Res 66, 4627-4635, 2006.
18. Scotti ML, Bamlet W, Smyrk TC, Fields AP, and Murray NR: Protein kinase C iota is required for pancreatic cancer cell transformed growth and tumorigenesis. Cancer Res 70, 2064-2074, 2010.
19. Kanthasamy AG, Kitazawa M, Yang Y, Anantharam V, and Kanthasamy A: Environmental neurotoxin dieldrin induces apoptosis via caspase-3 dependent proteolytic activation of protein kinase C delta: implications for neurodegeneration in Parkinson's disease. Molecular Brain 1, 12, 2008.
20. Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell 144, 646-674, 2011.
21. Shim H, Dolde C, Lewis BC,Wu CS, Dang G, et al.: c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc Natl Acad Sci 94, 6658-6663, 2007.
22. Dietz AA and Lubrano T: Separation and quantitation of lactic dehydrogenase isoenzymes by disc electrophoresis. Anal Biochem 20, 246-257, 1967.
23. Powell TC and Yin L: Over expression of PKC epsilon sensitizes LNCaP human prostate cancer cells to induction of apoptosis by bryostatin 1. Int J Cancer 118, 1572-1576, 2006.
24. Shahaf G, Rotem-Dai N, Koifman G, Raveh-Amit H, Frost SA, et al.: PKC is a negative regulator of AKT inhibiting the IGF-I induced proliferation. Exp Cell Res 15, 789-799, 2012.
25. Lu HC, Chou FP, Yeh KT, Chang YS, Hsu NC, et al.: Analysing the expression of protein kinase C eta in human hepatocellular carcinoma. Pathology 41, 626-629, 2009.
26. Voss OH, Kim S, Wewers MD, and Doseff AI: Regulation of monocyte apoptosis by the protein kinase C delta-dependent phosphorylation of caspase-3. J Biol Chem 280, 17371-17379, 2005.
27. Oh JI, Chun KH, Joo SH, Oh YT, and Lee SK: Caspase-3-dependent protein kinase C delta activity is required for the progression of Ginsenoside- Rh2 induced apoptosis in SK-HEP-1 cells. Cancer Letters 230, 228-238, 2005.
28. Panaretakis T, Laane E, Pokrovskaja K, and Björklund AC: Doxorubicin requires the sequential activation of caspase-2, protein kinase C delta, and c- Jun NH2-terminal kinase to induce apoptosis. Mol Biol Cell 16, 3821-3831, 2005.
29. Kim JW and Dang CV: Cancer's molecular sweet tooth and the Warburg effect. Cancer Res 66, 8927-8930, 2006.
30. Koukourakis M, Giatromanolaki A, Harris AL, and Sivridis E: Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor associated stroma. Cancer Res 66, 632-637, 2006.